New Haven Pharmaceuticals Receives $2M Venture Loan Facility from Horizon Technology Finance
New Haven Pharmaceuticals, Inc., a Guilford, CT-based developer of prescription pharmaceuticals that utilize currently marketed drugs or active pharmaceutical ingredients generally recognized as safe for use in therapeutic applications, closed a $2m venture loan facility with Horizon Technology Finance Corporation (Nasdaq: HRZN). The company intends to use facility for working capital purposes. Led by Patrick P. […]